Immuni T was founded by Dr. Luc Villeneuve in 2006 with a very simple goal: to perform research and development in support of pre-clinical and clinical studies of biotech and pharmaceutical companies. Our highly qualified team of experts and consultants successfully enhanced our clients’ resources for pre-clinical and clinical projects. We have been selected for several years in a row by big pharmaceutical companies around the world to perform their studies.

Our evolution continued, and today we have certified state-of-the-art facility in the heart of Montreal and offer the full range of immunological services and expertise to complement the drug development process from discovery to post-market. IMMUNI T has expensive networks with the academic and biotech community and benefit from pro-active partnering resources with four Universities comprising Concordia University, McGill University, Université de Montréal, Université du Québec à Montréal and all major University hospitals in the city, with high technology equipment platforms and competent human resources. We have developed significant expertise through experience in performing both standard and custom immuno-detection/diagnostic assays and assay validation. Our highly qualified scientific team with an average of 15 years experience in the life sciences industry are supporting many biotech and pharmaceutical companies around the world including USA, Canada, Australia, Europe, China and India.